Summary of efficacy outcomes in patients treated with lenalidomide monotherapy
Median values, mo . | Overall, N = 222 . | CR + PR, n = 58 . | CR + PR + MR, n = 98 . |
---|---|---|---|
Progression-free survival | 4.9* | 14.5 | 10.4 |
Time to progression | 5.2† | 14.5 | 10.4 |
Overall survival | 23.2‡ | 33.9 | 28.0 |
Median values, mo . | Overall, N = 222 . | CR + PR, n = 58 . | CR + PR + MR, n = 98 . |
---|---|---|---|
Progression-free survival | 4.9* | 14.5 | 10.4 |
Time to progression | 5.2† | 14.5 | 10.4 |
Overall survival | 23.2‡ | 33.9 | 28.0 |